Docusign Inc. (NASDAQ:DOCU) Given Consensus Rating of “Hold” by Analysts

Docusign Inc. (NASDAQ:DOCU) has been given an average rating of “Hold” by the twenty-one brokerages that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, fifteen have issued a hold rating and five have issued a buy rating on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $64.6667.

Several research analysts recently weighed in on DOCU shares. Wells Fargo & Company dropped their target price on shares of Docusign from $75.00 to $60.00 and set an “equal weight” rating for the company in a report on Wednesday, March 18th. Jefferies Financial Group cut Docusign from a “buy” rating to a “hold” rating and decreased their price target for the company from $105.00 to $45.00 in a report on Monday, February 23rd. UBS Group lowered their price objective on Docusign from $75.00 to $54.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 18th. BTIG Research reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Docusign in a research note on Wednesday, March 18th. Finally, Royal Bank Of Canada cut their target price on Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research report on Wednesday, March 18th.

Insiders Place Their Bets

In other news, CEO Allan C. Thygesen sold 26,250 shares of the business’s stock in a transaction on Friday, January 9th. The shares were sold at an average price of $69.60, for a total value of $1,827,000.00. Following the transaction, the chief executive officer owned 142,261 shares of the company’s stock, valued at approximately $9,901,365.60. The trade was a 15.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of the company’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total transaction of $281,040.00. Following the transaction, the executive owned 79,233 shares of the company’s stock, valued at approximately $3,711,273.72. This represents a 7.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 97,423 shares of company stock worth $5,359,699 over the last ninety days. 1.01% of the stock is owned by company insiders.

Institutional Trading of Docusign

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Central Pacific Bank Trust Division purchased a new stake in Docusign in the 4th quarter worth $25,000. Modus Advisors LLC bought a new position in shares of Docusign during the 4th quarter valued at about $27,000. Torren Management LLC purchased a new position in shares of Docusign during the fourth quarter valued at about $28,000. True Wealth Design LLC grew its position in shares of Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after purchasing an additional 222 shares in the last quarter. Finally, Aventura Private Wealth LLC bought a new stake in shares of Docusign in the fourth quarter worth about $30,000. 77.64% of the stock is currently owned by institutional investors.

Docusign Price Performance

Shares of NASDAQ:DOCU opened at $48.37 on Friday. Docusign has a 1-year low of $40.16 and a 1-year high of $94.67. The company has a market capitalization of $9.40 billion, a P/E ratio of 32.68, a P/E/G ratio of 1.88 and a beta of 0.99. The firm’s 50 day simple moving average is $47.40 and its two-hundred day simple moving average is $61.71.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The firm had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.86 earnings per share. On average, sell-side analysts anticipate that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign declared that its board has approved a share buyback program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
• Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
• Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
• Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
• Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
• Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
• Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.